SAR Studies on mGlu5 Receptor Positive Allosteric Modulators (2003- 2013)

E-ISSN： 1873-4294|14|15|1789-1841

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.14, Iss.15, 2014-08, pp. : 1789-1841

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Positive Allosteric Modulators (PAMs) of Metabotropic Glutamate Receptor 5 (mGluR5) Attenuate Microglial Activation

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 13, Iss. 4, 2014-06 ,pp. : 558-566

Bentham Science Publishers

Access to resources Recommend Favorite

Discovery of Positive Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 5 (mGluR5)

Current Topics in Medicinal Chemistry, Vol. 5, Iss. 9, 2005-08 ,pp. : 825-846

Bentham Science Publishers

Access to resources Recommend Favorite

Allosteric Modulators for mGlu Receptors

Current Neuropharmacology, Vol. 5, Iss. 3, 2007-09 ,pp. : 187-194

Bentham Science Publishers

Access to resources Recommend Favorite

mGlu₅ negative allosteric modulators: a patent review (2010 – 2012)

By Emmitte Kyle A

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 4, 2013-04 ,pp. : 393-408

Informa Healthcare

Access to resources Recommend Favorite

Metabotropic glutamate receptor 4 (mGlu₄)-positive allosteric modulators for the treatment of Parkinson's disease: historical perspective and review of the patent literature

By Lindsley Craig W Hopkins Corey R

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 5, 2012-05 ,pp. : 461-481

Informa Healthcare

Access to resources Recommend Favorite